Stem cell exosomes plus laser shows promise for stubborn melasma
NCT ID NCT06677931
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new treatment for melasma, a stubborn skin condition causing dark patches on the face. Researchers combined stem cell exosomes (tiny particles from umbilical cord cells) with a special laser in 30 adults. The goal was to see if this combo is safe and works better than laser alone. Results are being analyzed to see if it reduces pigmentation and repairs skin damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Union Hospital of Fujian Medical University
Fuzhou, Fujian, 350001, China
-
Chenxiaosong
Fujian, Fuzhou, 350001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- New serums take on hydroquinone in skin brightening showdown